
Triveni
Develops antibody-based therapeutics for immune and inflammatory diseases.
$65M Series B+ ·
Source: fundraisingfox.com
Funding history ↓Signals
Website registeredFeb 7, 2023 (3 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $65M | — | fundraisingfox.com |
Timeline
- Website created
Companies like Triveni
AAltruBio$225M Series B+ · May 2024
KK2 Therapeutics$50M Seed · Aug 2026
MMirador Therapeutics$250M Series B+ · Jan 2026
FFlip TherapeuticsSeed · Sep 2026
OOna Therapeutics$86.6M Series B+ · Oct 2026
AAbcuro$66M Series B+ · Aug 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/triveni (get a free API key).